DTC And FDA: “Brief Summary” Improvements Are Priority For McClellan

FDA will address physicians' "legitimate" concern that direct-to-consumer ads do not provide balanced risk-benefit information, Commissioner McClellan told the National Association of Health Underwriters legislative conference March 25 in Washington, D.C